Persistent lymphocytic leukemia (CLL) is related to immune dysfunction and an elevated danger of melanoma. For sufferers with metastatic melanoma, immunotherapy with checkpoint blocking antibodies is an ordinary of care. In sufferers with concomitant CLL and metastatic melanoma, it isn’t identified whether or not CLL would possibly affect the antimelanoma efficacy or immune-related toxicities of immune checkpoint blockade. Fifteen sufferers with domestically superior or metastatic melanoma and a concomitant prognosis of CLL who acquired pembrolizumab or ipilimumab with or with out nivolumab for the remedy of their melanoma at Memorial Sloan Kettering Most cancers Middle between January 1, 2010, and January 1, 2017, have been retrospectively recognized.

Medical traits together with absolute lymphocyte counts throughout remedy have been recorded together with a response to remedy (goal radiographic response, progression-free survival, and antagonistic occasions) for every affected person. Of 9 response-evaluable sufferers handled with ipilimumab, 3 (33%) had a partial response, 1 (11%) had steady illness, and 5 (56%) developed progressive illness. Goal tumor responses have been additionally noticed with single-agent remedy pembrolizumab and with mixture remedy of nivolumab and ipilimumab. Grade Three or four toxicity was noticed in 6 of 15 sufferers (40%), together with diarrhea, transaminitis, rash, and hemolytic anemia. Though our retrospective evaluation was restricted, there was no proof that CLL responded to the checkpoint blockade. This case collection demonstrates that ipilimumab, pembrolizumab, and mixed ipilimumab and nivolumab therapies present scientific exercise in sufferers with melanoma and concomitant CLL, at charges per these beforehand reported.

This inhabitants might warrant nearer surveillance for hematologic immune-related toxicities comparable to autoimmune hemolytic anemia. Dedication of human immunodeficiency virus-1 (HIV-1) genotypes and identification of antiretroviral drug-resistant mutations. Amongst remedy naïve HIV sufferers in Jazan, Saudi Arabia. HIV is a serious public well being drawback. HIV genotyping and antiretroviral resistance testing is a crucial information for higher administration of treatment-naive. Antiretroviral resistance testing earlier than beginning of remedy routine results in a greater virological response. A complete of 57 samples of treatment-naive sufferers have been collected from King Fahd Central Hospital in Jazan, Saudi Arabia. Samples have been examined for HIV-1 antibodies, western blot, viral load, HIV-1 genotypes by means of direct sequencing, and antiretroviral resistance testing.

Novel Auristatins with Excessive Bystander and Cytotoxic Actions in Drug-Efflux Constructive Tumor Fashions

Auristatins, a category of clinically validated anti-tubulin brokers utilized as payloads in antibody-drug conjugates, are typically labeled by their membrane permeability and the extent of cytotoxic bystander exercise on neighboring cells after focused supply. The medication usually fall inside two classes: membrane permeable monomethyl auristatin E (MMAE)-type molecules with excessive bystander actions and susceptibility to efflux pumps, or charged and fewer permeable monomethyl auristatin F (MMAF) analogues with low bystander actions and resistance to efflux pumps. Herein, we report the event of novel auristatins that mix the attributes of every class by having each bystander exercise and cytotoxicity on multidrug-resistant (MDR+) cell traces.

Construction-based design targeted on the hydrophobic functionalization of the N-terminal N-methylvaline of the MMAF scaffold to extend cell permeability. The ensuing structure-activity relationships of the brand new auristatins display that optimization of hydrophobicity and construction can result in extremely lively free medication and antibody-drug conjugates with in vivo bystander actions. Tembusu virus (TMUV) causes illness in poultry, particularly in geese, leading to abnormality in egg manufacturing and with excessive morbidity and mortality, leading to nice loss in duck farming trade in China and Southeast Asia.

Earlier research on the pathogenesis of TMUV an infection have been principally carried out in poultry, with a number of research being undertaken in mice. Whereas TMUV doesn’t trigger illness in people, it has been reported that antibodies in opposition to TMUV have been present in serum samples from duck farmers, and thus knowledge on TMUV an infection in people is proscribed, and the pathogenesis is unclear.

Past Blocking: Engineering RNAi-Mediated Focused Immune Checkpoint Nanoblocker Allows T-Cell-Impartial Most cancers Therapy

The emergence of immune checkpoint blockade to activate host T cells to assault tumor cells has revolutionized the most cancers remedy panorama over the previous decade. Nevertheless, sustained response has solely been achieved in a small proportion of sufferers. This may be attributed to physiological boundaries, comparable to T-cell heterogeneity and immunosuppressive tumor microenvironments. To this may be added obstacles intrinsic to conventional antibody-driven blockade strategies, together with the shortcoming to inhibit checkpoint translocation from cytoplasm, systemic immune toxicity, and “chunk again” impact on T cells.

Utilizing non-small cell lung most cancers (NSCLC) because the most cancers mannequin, right here we report an unconventional, but highly effective, tumor-targeted checkpoint blocking technique by RNAi nanoengineering for T-cell-independent most cancers remedy. Not like antibodies, such nanoblocker silences each membranous and cytoplasmic PD-L1 in most cancers cells, thus eliminating the binding step. Furthermore, it’s demonstrated that silencing of PD-L1 by the nanoblocker may cause the direct programmed cell loss of life of NSCLC H460 cells, with out the necessity of T-cell intervention.

 

Human major acute phase protein (MAP) ELISA kit

E01M0379-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human major acute phase protein (MAP) ELISA kit

E01M0379-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat major acute phase protein (MAP) ELISA kit

E06M0379-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Goat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat major acute phase protein (MAP) ELISA kit

E06M0379-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Goat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat major acute phase protein (MAP) ELISA kit

E06M0379-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Goat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog major acute phase protein (MAP) ELISA kit

E08M0379-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog major acute phase protein (MAP) ELISA kit

E08M0379-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Canine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog major acute phase protein (MAP) ELISA kit

E08M0379-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Canine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat major acute phase protein (MAP) ELISA kit

E02M0379-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat major acute phase protein (MAP) ELISA kit

E02M0379-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat major acute phase protein (MAP) ELISA kit

E02M0379-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse major acute phase protein (MAP) ELISA kit

E03M0379-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Mouse major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse major acute phase protein (MAP) ELISA kit

E03M0379-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Mouse major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse major acute phase protein (MAP) ELISA kit

E03M0379-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Mouse major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit major acute phase protein (MAP) ELISA kit

E04M0379-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rabbit major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit major acute phase protein (MAP) ELISA kit

E04M0379-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rabbit major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit major acute phase protein (MAP) ELISA kit

E04M0379-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rabbit major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig major acute phase protein (MAP) ELISA kit

E07M0379-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig major acute phase protein (MAP) ELISA kit

E07M0379-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig major acute phase protein (MAP) ELISA kit

E07M0379-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Porcine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Porcine MAP(major acute phase protein) ELISA Kit

EP0218 96T
EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Pig;Sensitivity: 0.938 ng/ml

Pig Major Acute Phase Protein (MAP) ELISA Kit

abx051245-96tests 96 tests
EUR 990

Monkey major acute phase protein (MAP) ELISA kit

E09M0379-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Monkey major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey major acute phase protein (MAP) ELISA kit

E09M0379-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Monkey major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey major acute phase protein (MAP) ELISA kit

E09M0379-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Monkey major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Porcine major acute phase protein (MAP) ELISA Kit

QY-E40002 96T
EUR 472.8

Cat Serum Amyloid A (SAA) Protein

abx670164-01mg 0.1 mg
EUR 1144.8

Nori® Porcine 6-Plex ELISA Kits-SAA

GR224030 96-well
EUR 754.8

Nori® Equine 6-Plex ELISA Kits-SAA

GR225030 96-well
EUR 754.8

Nori® Canine 6-Plex ELISA Kits-SAA

GR226030 96-well
EUR 754.8

Nori® Bovine 6-Plex ELISA Kits-SAA

GR228030 96-well
EUR 754.8

Guinea pig major acute phase protein (MAP) ELISA kit

E05M0379-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Guinea pig major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig major acute phase protein (MAP) ELISA kit

E05M0379-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Guinea pig major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig major acute phase protein (MAP) ELISA kit

E05M0379-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Guinea pig major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

MAP ELISA Kit| Porcine major acute phase protein ELISA Kit

EF016757 96 Tests
EUR 826.8

Human Catalase (CAT) ELISA Kit

DLR-CAT-Hu-48T 48T
EUR 529.2
Description: A sandwich quantitative ELISA assay kit for detection of Human Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Catalase (CAT) ELISA Kit

DLR-CAT-Hu-96T 96T
EUR 684
Description: A sandwich quantitative ELISA assay kit for detection of Human Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Catalase (CAT) ELISA Kit

DLR-CAT-Mu-48T 48T
EUR 632.4
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Catalase (CAT) ELISA Kit

DLR-CAT-Mu-96T 96T
EUR 825.6
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids.

Rat Catalase (CAT) ELISA Kit

DLR-CAT-Ra-48T 48T
EUR 658.8
Description: A sandwich quantitative ELISA assay kit for detection of Rat Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids.

Rat Catalase (CAT) ELISA Kit

DLR-CAT-Ra-96T 96T
EUR 861.6
Description: A sandwich quantitative ELISA assay kit for detection of Rat Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Catalase (CAT) ELISA Kit

RDR-CAT-Hu-48Tests 48 Tests
EUR 546

Human Catalase (CAT) ELISA Kit

RDR-CAT-Hu-96Tests 96 Tests
EUR 754.8

Mouse Catalase (CAT) ELISA Kit

RDR-CAT-Mu-48Tests 48 Tests
EUR 668.4

Mouse Catalase (CAT) ELISA Kit

RDR-CAT-Mu-96Tests 96 Tests
EUR 928.8

Rat Catalase (CAT) ELISA Kit

RDR-CAT-Ra-48Tests 48 Tests
EUR 699.6

Rat Catalase (CAT) ELISA Kit

RDR-CAT-Ra-96Tests 96 Tests
EUR 973.2

Human Catalase (CAT) ELISA Kit

RD-CAT-Hu-48Tests 48 Tests
EUR 523.2

Human Catalase (CAT) ELISA Kit

RD-CAT-Hu-96Tests 96 Tests
EUR 721.2

Mouse Catalase (CAT) ELISA Kit

RD-CAT-Mu-48Tests 48 Tests
EUR 639.6

Mouse Catalase (CAT) ELISA Kit

RD-CAT-Mu-96Tests 96 Tests
EUR 888

Rat Catalase (CAT) ELISA Kit

RD-CAT-Ra-48Tests 48 Tests
EUR 668.4

Rat Catalase (CAT) ELISA Kit

RD-CAT-Ra-96Tests 96 Tests
EUR 930

Bovine Serum Amyloid A (SAA) ELISA Kit

DLR-SAA-b-48T 48T
EUR 656.4
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Serum Amyloid A (SAA) in samples from serum, plasma or other biological fluids.

Bovine Serum Amyloid A (SAA) ELISA Kit

DLR-SAA-b-96T 96T
EUR 858
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Serum Amyloid A (SAA) in samples from serum, plasma or other biological fluids.

Human Serum Amyloid A (SAA) ELISA Kit

DLR-SAA-Hu-48T 48T
EUR 574.8
Description: A sandwich quantitative ELISA assay kit for detection of Human Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Serum Amyloid A (SAA) ELISA Kit

DLR-SAA-Hu-96T 96T
EUR 745.2
Description: A sandwich quantitative ELISA assay kit for detection of Human Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Mouse Serum Amyloid A (SAA) ELISA Kit

DLR-SAA-Mu-48T 48T
EUR 586.8
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Mouse Serum Amyloid A (SAA) ELISA Kit

DLR-SAA-Mu-96T 96T
EUR 762
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Rabbit Serum Amyloid A (SAA) ELISA Kit

DLR-SAA-Rb-48T 48T
EUR 609.6
Description: A sandwich quantitative ELISA assay kit for detection of Rabbit Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Rabbit Serum Amyloid A (SAA) ELISA Kit

DLR-SAA-Rb-96T 96T
EUR 793.2
Description: A sandwich quantitative ELISA assay kit for detection of Rabbit Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Bovine Serum Amyloid A (SAA) ELISA Kit

RD-SAA-b-48Tests 48 Tests
EUR 666

Bovine Serum Amyloid A (SAA) ELISA Kit

RD-SAA-b-96Tests 96 Tests
EUR 925.2

Human Serum Amyloid A (SAA) ELISA Kit

RD-SAA-Hu-48Tests 48 Tests
EUR 573.6

Human Serum Amyloid A (SAA) ELISA Kit

RD-SAA-Hu-96Tests 96 Tests
EUR 794.4

Mouse Serum Amyloid A (SAA) ELISA Kit

RD-SAA-Mu-48Tests 48 Tests
EUR 586.8

Mouse Serum Amyloid A (SAA) ELISA Kit

RD-SAA-Mu-96Tests 96 Tests
EUR 812.4

Rabbit Serum Amyloid A (SAA) ELISA Kit

RD-SAA-Rb-48Tests 48 Tests
EUR 613.2

Rabbit Serum Amyloid A (SAA) ELISA Kit

RD-SAA-Rb-96Tests 96 Tests
EUR 850.8

Bovine Serum Amyloid A (SAA) ELISA Kit

RDR-SAA-b-48Tests 48 Tests
EUR 696

Bovine Serum Amyloid A (SAA) ELISA Kit

RDR-SAA-b-96Tests 96 Tests
EUR 968.4

Human Serum Amyloid A (SAA) ELISA Kit

RDR-SAA-Hu-48Tests 48 Tests
EUR 600

Human Serum Amyloid A (SAA) ELISA Kit

RDR-SAA-Hu-96Tests 96 Tests
EUR 830.4

Mouse Serum Amyloid A (SAA) ELISA Kit

RDR-SAA-Mu-48Tests 48 Tests
EUR 613.2

Mouse Serum Amyloid A (SAA) ELISA Kit

RDR-SAA-Mu-96Tests 96 Tests
EUR 850.8

Rabbit Serum Amyloid A (SAA) ELISA Kit

RDR-SAA-Rb-48Tests 48 Tests
EUR 640.8

Rabbit Serum Amyloid A (SAA) ELISA Kit

RDR-SAA-Rb-96Tests 96 Tests
EUR 890.4

Mouse Anti-Cat SAA monoclonal antibody

CABT-BL8902 1.0 mg
EUR 1189.2

Anti-Cat SAA Protein Antibody | MSAA-20A-1C12

MSAA-20A-1C12 1.0 mg
EUR 637
Description:

Anti-Cat SAA Protein Antibody | MSAA-20A-1C12 | Immunology Consultants Laboratory

Host: Mouse

Format: Unconjugated AP

Product Type: Primary Antibody

Antibody Clonality: Monoclonal

Anti-Cat SAA Protein Antibody | MSAA-20A-3A5

MSAA-20A-3A5 1.0 mg
EUR 637
Description:

Anti-Cat SAA Protein Antibody | MSAA-20A-3A5 | Immunology Consultants Laboratory

Host: Mouse

Format: Unconjugated AP

Product Type: Primary Antibody

Antibody Clonality: Monoclonal

Anti-Cat SAA Protein Antibody | MSAA-20A-4B2

MSAA-20A-4B2 1.0 mg
EUR 637
Description:

Anti-Cat SAA Protein Antibody | MSAA-20A-4B2 | Immunology Consultants Laboratory

Host: Mouse

Format: Unconjugated AP

Product Type: Primary Antibody

Antibody Clonality: Monoclonal

TruStrip RDT Human Serum Amyloid A (SAA) Rapid Test cards, 10 tests/pack

SAA-RDT-10 1 pack
EUR 205.2

TruStrip RDT Human Serum Amyloid A (SAA) Rapid Test cards, 25 tests/pack

SAA-RDT-25 1 pack
EUR 351.6

Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed

ELISA-1 1
EUR 242.4

SAA Protein

abx060299-100ug 100 ug
EUR 994.8

SAA-PEG-SAA

abx085047-10kDa1g 10 kDa; 1 g
EUR 543.6

SAA-PEG-SAA

abx085047-1kDa1g 1 kDa; 1 g
EUR 543.6

SAA-PEG-SAA

abx085047-20kDa1g 20 kDa; 1 g
EUR 543.6

SAA-PEG-SAA

abx085047-2kDa1g 2 kDa; 1 g
EUR 543.6

Recombinant Trypanosoma Cruzi Shed-acute-phase-antigen Protein (aa 61-460) (Yeast) [His]

VAng-Wyb8481-100g 100 µg
EUR 5652
Description: Trypanosoma Cruzi Shed-acute-phase-antigen protein, recombinant protein.

Recombinant Trypanosoma Cruzi Shed-acute-phase-antigen Protein (aa 61-460) (Yeast) [His]

VAng-Wyb8481-500g 500 µg
EUR 14743.2
Description: Trypanosoma Cruzi Shed-acute-phase-antigen protein, recombinant protein.

CAT/ Rat CAT ELISA Kit

ELA-E0242r 96 Tests
EUR 1063.2

SAA-PEG-SAA,10K

33-HO015015-10K
  • EUR 310.80
  • EUR 812.40
  • 1g
  • 5g
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

SAA-PEG-SAA,1K

33-HO015015-1K
  • EUR 310.80
  • EUR 812.40
  • 1g
  • 5g
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

SAA-PEG-SAA,20K

33-HO015015-20K
  • EUR 310.80
  • EUR 812.40
  • 1g
  • 5g
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

SAA-PEG-SAA,2K

33-HO015015-2K
  • EUR 310.80
  • EUR 812.40
  • 1g
  • 5g
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

SAA-PEG-SAA,3.4K

33-HO015015-3.4K
  • EUR 310.80
  • EUR 812.40
  • 1g
  • 5g
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

SAA-PEG-SAA,5K

33-HO015015-5K
  • EUR 310.80
  • EUR 812.40
  • 1g
  • 5g
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

SAA

E64C01201 20ug
EUR 458.4

Recombinant Trypanosoma Cruzi Shed-acute-phase-antigen Protein (aa 61-460) (E. coli) [His]

VAng-Wyb8480-100g 100 µg
EUR 4002
Description: Trypanosoma Cruzi Shed-acute-phase-antigen protein, recombinant protein.

Recombinant Trypanosoma Cruzi Shed-acute-phase-antigen Protein (aa 61-460) (E. coli) [His]

VAng-Wyb8480-500g 500 µg
EUR 9794.4
Description: Trypanosoma Cruzi Shed-acute-phase-antigen protein, recombinant protein.

Human SAA ELISA Kit

DEIA450 96T
EUR 1272
Description: ThisHuman SAA ELISA Kit is to be used for the in vitro quantitative determinationof human serum amyloid A (SAA) concentrations in serum, plasma, cell culture supernatant, and other biological fluids.

Chicken SAA ELISA Kit

E-30SAA 1 x 96 well plate
EUR 590.4

Dog SAA ELISA Kit

E-40SAA 1 x 96 well plate
EUR 553.2

Horse SAA ELISA Kit

E-70SAA 1 x 96 well plate
EUR 620.4

Human SAA ELISA Kit

E-80SAA 1 x 96 well plate
EUR 553.2

Mouse SAA ELISA Kit

E-90SAA 1 x 96 well plate
EUR 474

Sheep SAA ELISA Kit

ESS0235 96Tests
EUR 625.2

Human SAA ELISA Kit

EHS0235 96Tests
EUR 625.2

Porcine SAA ELISA Kit

EPS0235 96Tests
EUR 625.2

Monkey SAA ELISA Kit

EMKS0235 96Tests
EUR 625.2

Mouse SAA ELISA Kit

EMS0235 96Tests
EUR 625.2

Rat SAA ELISA Kit

ERS0235 96Tests
EUR 625.2

Rabbit SAA ELISA Kit

ERTS0235 96Tests
EUR 625.2

Goat SAA ELISA Kit

EGTS0235 96Tests
EUR 625.2

Anserini SAA ELISA Kit

EAS0235 96Tests
EUR 625.2

Bovine SAA ELISA Kit

EBS0235 96Tests
EUR 625.2

Chicken SAA ELISA Kit

ECKS0235 96Tests
EUR 625.2

Canine SAA ELISA Kit

ECS0235 96Tests
EUR 625.2

SAA ELISA KIT|Human

EF000259 96 Tests
EUR 826.8

Goat Acite Phase Protein

QY-E140096 96T
EUR 495.6

SAA antibody

20-1715 1 ml
EUR 165.6
Description: Goat polyclonal SAA antibody

SAA antibody

10R-10351 100 ug
EUR 522
Description: Mouse monoclonal SAA antibody

SAA antibody

10-7959 500 ug
EUR 418.8
Description: Mouse monoclonal SAA antibody

SAA antibody

10-7960 500 ug
EUR 418.8
Description: Mouse monoclonal SAA antibody

mPEG-SAA

abx085023-10kDa1g 10 kDa; 1 g
EUR 444

mPEG-SAA

abx085023-1kDa1g 1 kDa; 1 g
EUR 427.2

mPEG-SAA

abx085023-20kDa1g 20 kDa; 1 g
EUR 444

mPEG-SAA

abx085023-2kDa1g 2 kDa; 1 g
EUR 427.2

mPEG-SAA

abx085023-5kDa1g 5 kDa; 1 g
EUR 427.2

Bovine(SAA)

QY-E60061 96T
EUR 511.2

Apo-SAA Recombinant Protein

40-129-001mg 0.01 mg
EUR 311.1
Description: Human apo-SAA is a 104 amino acid polypeptide that circulates primarily in association with high-density lipoproteins (HDL). The level of apo-SAA, normally 1-5 µg/mL in plasma, increases 500-1000 fold within 24 hours of an inflammatory stimulus and, under these conditions, is the most abundant HDL apo-lipoprotein. The human SAA gene codes for a 122 amino acid polypeptide, which contains an 18 amino acid N-terminal signal sequence. Recombinant Apo-SAA is a consensus SAA molecule corresponding to human apo-SAA1alpha except for the presence of an N-terminal methionine and substitution of asparagine for aspartic acid at position 60 and arginine for histidine at position 71(the later two substituted residues are present in apo-SAA2beta).

Apo-SAA Recombinant Protein

40-129-005mg 0.05 mg
EUR 437.1
Description: Human apo-SAA is a 104 amino acid polypeptide that circulates primarily in association with high-density lipoproteins (HDL). The level of apo-SAA, normally 1-5 µg/mL in plasma, increases 500-1000 fold within 24 hours of an inflammatory stimulus and, under these conditions, is the most abundant HDL apo-lipoprotein. The human SAA gene codes for a 122 amino acid polypeptide, which contains an 18 amino acid N-terminal signal sequence. Recombinant Apo-SAA is a consensus SAA molecule corresponding to human apo-SAA1alpha except for the presence of an N-terminal methionine and substitution of asparagine for aspartic acid at position 60 and arginine for histidine at position 71(the later two substituted residues are present in apo-SAA2beta).

Human Steroidogenic acute regulatory protein ELISA kit

E01S0208-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Steroidogenic acute regulatory protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Steroidogenic acute regulatory protein ELISA kit

E01S0208-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Steroidogenic acute regulatory protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Steroidogenic acute regulatory protein ELISA kit

E01S0208-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Steroidogenic acute regulatory protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Steroidogenic acute regulatory protein ELISA kit

E04S0208-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rabbit Steroidogenic acute regulatory protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

In vivo outcomes from xenograft tumor fashions additional display that tumor-homing peptide modification permits the nanoblocker to build up within the tumor tissue, downregulate the PD-L1 expression, and inhibit the tumor development extra effectively than the nontargeted group. These findings might provide an efficient means towards overcoming boundaries in opposition to conventional checkpoint blockade and supply completely different insights into the molecular mechanism(s) underlying immunotherapy.